VERA
Price:
$35.09
Market Cap:
$2.52B
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is atacicept, a fusion protein that patients self-administer as a subcutaneous injection. This drug is currently undergoing Phase IIb clinical trials to treat immunoglobulin A nephropathy. The company is also advancing MAU868, a monoclonal antibody in Phase 2 clinical development, designed to combat BK viremia infections. Founded in 2016 and based in Brisbane, California, the organization operated as Trucode Gene Repair, Inc. until it rebranded to Vera T...[Read more]
Industry
Biotechnology
IPO Date
2021-05-14
Stock Exchange
NASDAQ
Ticker
VERA
According to Vera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.33. This represents a change of -1.61% compared to the average of -6.43 of the last 4 quarters.
The mean historical PE Ratio of Vera Therapeutics, Inc. over the last ten years is -7.71. The current -6.33 PE Ratio has changed 8.11% with respect to the historical average. Over the past ten years (40 quarters), VERA's PE Ratio was at its highest in in the December 2020 quarter at -1.38. The PE Ratio was at its lowest in in the March 2024 quarter at -18.91.
Average
-7.71
Median
-6.84
Minimum
-15.38
Maximum
-0.80
Discovering the peaks and valleys of Vera Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.28%
Maximum Annual PE Ratio = -0.80
Minimum Annual Increase = -75.97%
Minimum Annual PE Ratio = -15.38
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -10.87 | -29.34% |
| 2024 | -15.38 | 124.97% |
| 2023 | -6.84 | 18.34% |
| 2022 | -5.78 | -47.47% |
| 2021 | -11.00 | 1.28% |
| 2020 | -0.80 | -75.97% |
The current PE Ratio of Vera Therapeutics, Inc. (VERA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.03
5-year avg
-9.97
10-year avg
-7.71
Vera Therapeutics, Inc.’s PE Ratio is greater than Celldex Therapeutics, Inc. (-7.59), greater than AbCellera Biologics Inc. (-11.52), greater than Janux Therapeutics, Inc. (-7.73), less than Viridian Therapeutics, Inc. (-4.78), greater than Pharvaris N.V. (-10.10), greater than Immunome, Inc. (-7.84), less than Biohaven Ltd. (-2.39), greater than uniQure N.V. (-13.19), less than Harmony Biosciences Holdings, Inc. (13.21), greater than Nuvation Bio Inc. (-13.10),
| Company | PE Ratio | Market cap |
|---|---|---|
| -7.59 | $2.16B | |
| -11.52 | $1.69B | |
| -7.73 | $867.20M | |
| -4.78 | $1.50B | |
| -10.10 | $2.29B | |
| -7.84 | $1.79B | |
| -2.39 | $1.44B | |
| -13.19 | $2.92B | |
| 13.21 | $1.93B | |
| -13.10 | $1.93B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Vera Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Vera Therapeutics, Inc. (VERA)?
What is the highest PE Ratio for Vera Therapeutics, Inc. (VERA)?
What is the 3-year average PE Ratio for Vera Therapeutics, Inc. (VERA)?
What is the 5-year average PE Ratio for Vera Therapeutics, Inc. (VERA)?
How does the current PE Ratio for Vera Therapeutics, Inc. (VERA) compare to its historical average?